Sanofi weighs takeover of US drugmaker Insmed, Bloomberg News reports
Key Points:
- Shares of Insmed surged 14%, with the company valued at $26.28 billion according to LSEG data.
- French drugmaker Sanofi is reportedly in talks with advisers about a potential acquisition of Insmed, as per Bloomberg sources.
- Sanofi has declined to comment on market rumors regarding the possible deal.
- Discussions are ongoing and any agreement could take several weeks to finalize.